(Q43902939)

27 November 2017

title

Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells (English)

1 reference

27 November 2017

1 reference

Han J

1

1 reference

27 November 2017

Goldstein LA

2

1 reference

27 November 2017

Gastman BR

3

1 reference

27 November 2017

Rabinovitz A

4

1 reference

27 November 2017

Wang GQ

5

1 reference

27 November 2017

Fang B

6

1 reference

27 November 2017

Rabinowich H

7

1 reference

27 November 2017

publication date

1 October 2004

1 reference

27 November 2017

1 reference

27 November 2017

volume

18

1 reference

27 November 2017

issue

10

1 reference

27 November 2017

page(s)

1671-1680

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403496

27 November 2017

exact match

0 references

cites work

Apoptotic pathways: paper wraps stone blunts scissors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Structural basis of IAP recognition by Smac/DIABLO

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Role of BAX in the apoptotic response to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Resistance to granzyme B-mediated cytochrome c release in Bak-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

A role for mitochondrial Bak in apoptotic response to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

A unified model for apical caspase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Insights into the regulatory mechanism for caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Apoptosis control by death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Cell death regulation by the mammalian IAP antagonist Diablo/Smac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

VDAC2 inhibits BAK activation and mitochondrial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

7 January 2021

Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

7 January 2021

Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

7 January 2021

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403496

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403496

1 reference

Dimensions Publication ID

27 November 2017

1022268671

0 references

1 reference